Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low vs High Dose Methylprednisolone in Severe MPP
NCT02303587Completed
- Sponsor
- Beijing Children's Hospital
- Start
- Dec 2014
- Primary completion
- Oct 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial of methylprednisolone in Mycoplasma pneumonia (2 arms), sponsored by Beijing Children's Hospital. Primary endpoint: Number of pulmonary lesions (atelectasis, bronchiectasis, bronchiolitis obliterans, or consolidations) at 6 months. Started Dec 2014; status: completed.
02
Drugs
methylprednisolone
03
Conditions
Mycoplasma pneumonia
Beyond the preview
Go deeper on NCT02303587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02303587.